| EPC233 | Knowledge, attitude and perception of uninitiated adolescents towards customary male initiation practices in selected schools in Buffalo City Municipality, Eastern Cape | E-poster | Scale up of medical male circumcision |
| EPC234 | District-level coverage and unmet need for medical and traditional circumcision among men aged 10-29 years in sub-Saharan Africa | E-poster | Scale up of medical male circumcision |
| EPA083 | Evidence of recurrent selection of mutations commonly found in SARS-CoV-2 variants of concern in viruses infecting immunocompromised patients | E-poster | SARS-Cov2 Viral origins, evolution and diversity |
| EPA087 | Limited immunogenicity of SARS-CoV-2 vaccine in people living with HIV (PWH) and low nadir CD4 counts | E-poster | SARS-Cov2 vaccines |
| EPA088 | Adverse events following COVID-19 vaccination among people with HIV: review of available vaccine safety literature | E-poster | SARS-Cov2 vaccines |
| EPA089 | Potent cytotoxic activity against SARS-CoV-2 of CD8+ T cells from individuals with HIV who received complete schedule of COVID-19 vaccines | E-poster | SARS-Cov2 vaccines |
| EPA090 | Factors associated with SARS-CoV2 vaccination acceptance in people with HIV participating in the SCAPE-HIV study | E-poster | SARS-Cov2 vaccines |
| EPA091 | Immunogenicity of mRNA-1273 COVID-19 vaccination in PLWH after inadequate primary vaccination response | E-poster | SARS-Cov2 vaccines |
| EPA092 | SARS-CoV-2 Omicron Spike recognition by plasma fromindividuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between doses | E-poster | SARS-Cov2 vaccines |
| EPA093 | Detection of pre-existing neutralizing antibodies against Ad26 in HIV-1-infected Individuals not responding to the Ad26.COV2.S vaccine | E-poster | SARS-Cov2 vaccines |